The study of metabolism and metabolomics in a mouse model of silica pulmonary fibrosis based on UHPLC-QE-MS
Source abstract
Abstract
The small diameter crystalline silica is inhaled into the lung and cannot be cleared. As a result, the patient suffers from silicosis, a lung disease for which there is no effective treatment except lung transplantation. The aim of this study is to reveal the histological, cytological and metabolic characteristics of mice with pulmonary fibrosis induced by different doses of silica, and to provide an ideal animal model for drug development and disease research of pulmonary fibrosis. The experimental mice were divided into five groups. The mice were sacrificed 42 d later by nasal inhalation of normal saline and suspension containing silica 1 mg, 2 mg, 4 mg and 8 mg. Lung specimens and bronchoalveolar lavage fluid (BALF) were collected for histological and cytological examination. Carotid blood was collected and centrifuged to obtain serum for UHPLC-QE-MS non-target metabolomics detection. Compared with the normal control group, except 1 mg silica group, the other dosage groups showed different degree of disease characteristics. Metabolomics analysis showed that arginine and proline metabolism, pentose phosphate pathway, histidine metabolism, cysteine and methionine metabolism, ascorbic acid and aldoglucose metabolism were important metabolic pathways. This study reveals the histological, cytological and metabolic features of four-dose-gradient silica-induced pulmonary fibrosis mouse models.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis · Occupational and environmental lung diseases · Medical Imaging and Pathology Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Baotou Medical College, Baotou, China
Department of Cardiovascular Diseases, First Affiliated Hospital of Baotou Medical College, Baotou, China
Funding
National Natural Science Foundation of China · Natural Science Foundation of Inner Mongolia, China · Scientific Technology Plan Project of Inner Mongolia, China · Innovation and Entrepreneurship Training Program for College Students
References (27)
Show source-provided references
1. 10.3390/ijms2215811010.3390/ijms22158110 ↗
2. 10.3390/ijms2201045310.3390/ijms22010453 ↗
3. 10.1007/BF0289583210.1007/BF02895832 ↗
4. 10.1016/j.pupt.2018.06.00310.1016/j.pupt.2018.06.003 ↗
5. 10.1007/s00420-021-01729-410.1007/s00420-021-01729-4 ↗
6. 10.7150/thno.2968210.7150/thno.29682 ↗
7. 10.1016/j.trsl.2019.02.00110.1016/j.trsl.2019.02.001 ↗
8. 10.1165/rcmb.2017-0287OC10.1165/rcmb.2017-0287OC ↗
9. 10.1080/21691401.2020.181431510.1080/21691401.2020.1814315 ↗
10. Mirsaeidi M, Banoei MM, Nienow CK, et al. Plasma metabolomic profile in fibrosing pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2016;33(1):29–38.
11. 10.1186/s12890-021-01462-110.1186/s12890-021-01462-1 ↗
12. 10.1136/bmjresp-2017-00018310.1136/bmjresp-2017-000183 ↗
13. 10.1097/JOM.000000000000223210.1097/JOM.0000000000002232 ↗
14. 10.3390/ijms2120774610.3390/ijms21207746 ↗
15. 10.1016/j.hlc.2016.12.02010.1016/j.hlc.2016.12.020 ↗
16. 10.1080/10715762.2019.166077710.1080/10715762.2019.1660777 ↗
17. 10.1016/j.scitotenv.2020.13679010.1016/j.scitotenv.2020.136790 ↗
18. 10.7575/aiac.abcmed.v.6n.1p.110.7575/aiac.abcmed.v.6n.1p.1 ↗
19. 10.3390/nu1203084810.3390/nu12030848 ↗
20. 10.1007/s00204-020-02657-x10.1007/s00204-020-02657-x ↗
21. 10.5551/jat.570210.5551/jat.5702 ↗
22. 10.1093/jn/nxaa24310.1093/jn/nxaa243 ↗
23. 10.1016/j.biocel.2003.11.01610.1016/j.biocel.2003.11.016 ↗
24. 10.1007/s00726-017-2494-210.1007/s00726-017-2494-2 ↗
25. 10.1152/ajpcell.00586.202010.1152/ajpcell.00586.2020 ↗
26. 10.1021/acs.jproteome.6b0015610.1021/acs.jproteome.6b00156 ↗
27. 10.3390/antiox811051910.3390/antiox8110519 ↗